Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138


Are the MADIT II criteria for ICD implantation appropriate for Japanese patients?

Tanno K, Miyoshi F, Watanabe N, Minoura Y, Kawamura M, Ryu S, Asano T, Kobayashi Y, Katagiri T; MADIT II. The Multicenter Automtic Defibrillator Implantation Trial.

Circ J. 2005 Jan;69(1):19-22.


Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?

Siu CW, Pong V, Ho HH, Liu S, Lau CP, Li SW, Tse HF.

J Cardiovasc Electrophysiol. 2010 Mar;21(3):231-5. doi: 10.1111/j.1540-8167.2009.01609.x. Epub 2009 Oct 5.


Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.

Sharma PP, Greenlee RT, Anderson KP, Chyou PH, Osorio HJ, Smith PN, Hayes JH, Vidaillet H.

J Interv Card Electrophysiol. 2007 Sep;19(3):157-64. Epub 2007 Sep 6.


Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.


Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.

Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT Jr.

Circulation. 2004 Oct 5;110(14):1885-9. Epub 2004 Sep 27.


Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.

Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):293-9.


[Prevalence and clinical course of patients in Spain with acute myocardial infarction and severely depressed ejection fraction who meet the criteria for automatic defibrillator implantation].

Martí Almor J, Delclós Baulies M, Delclós Urgell J, Comín Colet J, Cladellas Capdevila M, Bruguera Cortada J.

Rev Esp Cardiol. 2004 Jul;57(7):705-8. Spanish.


Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ; MADIT-II Investigators.

J Am Coll Cardiol. 2005 Nov 1;46(9):1712-20. Epub 2005 Oct 10.


Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ; MADIT II Study Investigators.

J Am Coll Cardiol. 2006 Jan 3;47(1):98-107. Epub 2005 Dec 15.


Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.

Curtis AB, Cannom DS, Bigger JT Jr, DiMarco JP, Estes NA 3rd, Steinman RC, Parides MK.

Am Heart J. 1997 Nov;134(5 Pt 1):787-98.


Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU; MADIT-II Investigators.

J Am Coll Cardiol. 2006 May 2;47(9):1811-7. Epub 2006 Apr 17.


Impact of the multicenter automatic defibrillator implantation trial on clinical practice.

Ho IC, Passeri JJ, Guy ML, Ruskin JN, Ellinor PT.

Ann Noninvasive Electrocardiol. 2006 Jan;11(1):20-7.


Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators.

J Am Coll Cardiol. 2008 Apr 8;51(14):1357-65. doi: 10.1016/j.jacc.2007.09.073.


Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.

Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I; Multicenter Automatic Defibrillator Implantation Trial-II Investigators.

Am J Cardiol. 2010 Mar 1;105(5):581-6. doi: 10.1016/j.amjcard.2009.10.041. Epub 2010 Jan 22.


Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.

Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2007 Feb;18(2):181-4.


Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P.

Circulation. 2009 Jul 21;120(3):194-200. doi: 10.1161/CIRCULATIONAHA.108.836791. Epub 2009 Jul 6.

Supplemental Content

Support Center